BioSpace News Archive

Fasola will succeed the current CEO Barry M. Smith, who will remain to assist with the transition as needed.

Recent Equity Raise and Line of Credit Provides Working Capital and Strengthened Balance Sheet to Fund Growth and Profitability

IntelGenx Corp., a leader in pharmaceutical films, announced that it has progressed to the manufacturing scale-up stage in its cannabis-infused VersaFilm® product co-development program.

Zenith Capital Corp. announces that, at its annual and special meeting of shareholders held earlier, Zenith shareholders approved all resolutions outlined in the Notice of Meeting and Management Information Circular dated September 16, 2019, which is available on SEDAR at www.sedar.com, and on the Zenith website at www.zenithepigenetics.com.

Mesa Laboratories, Inc., a diversified supplier of quality control instruments and consumables to highly regulated markets announced the acquisition of Gyros Protein Technologies Holding AB

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today reported financial results for its third quarter ended September 30, 2019.

Highly statistically significant activity relative to vehicle across every assessed symptom and sign observed in allergen chamber clinical trial

Analyses of tebentafusp data provide further insight into platform’s mechanism of action, potential link to clinical activity in uveal melanoma

Successful conclusion of an End of Phase II meeting with the FDA

Obalon Therapeutics, Inc. announces that it plans to release its third quarter 2019 financial results before the market opens on Friday, November 8, 2019 and hold a conference call at 9:00 AM Eastern Time to discuss the Company’s financial results and provide a business update.